Aurobac Therapeutics SAS

	Start	2021-10-18 established jv
	Group	Boehringer Ingelheim (Group)
	Industry	drug discovery
	Industry 2	antibiotic

	Region	Lyon
	Country	France
	Street	29 avenue Tony Garnier
	City	69007 Lyon
		Address record changed: 2022-07-07

Basic data	Employees	n. a.


		Record changed: 2025-03-16

Picture GASB Event SynBioReactor Summit 2026 Berlin January v4 650x200px

More documents for Boehringer Ingelheim (Group)

[1] Boehringer Ingelheim. (10/2/23). "Press Release: Boehringer Ingelheim and Zeiss Join Forces to Early Detect Eye Diseases and Prevent Vision Loss". Ingelheim & Jena....
[2] Evotec SE. (7/6/22). "Press Release: Evotec, Boehringer Ingelheim, and bioMérieux Launch Aurobac, a Joint Venture to Fight Antimicrobial Resistance". Germany & France....
[3] Brainomix Ltd.. (2/1/22). "Press Release: Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-powered Radiomic Software for Automated Assessment of Solid Tumor Cancer". Oxford....
[4] Biognosys AG. (7/23/20). "Press Release: Boehringer Ingelheim and Biognosys Join Forces on Applying Quantitative Proteomics Tools in Drug Discovery". Biberach & Schlieren....
[5] Genedata AG. (2/26/20). "Press Release: Leading Biopharma Experts Drive R&D Innovation and Process Efficiency at the Genedata Partner Symposium". Basel....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com